| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
36,107,000 |
| Market
Cap: |
293.37(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$6.87 - $26.45 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with needs in inflammatory diseases and oncology. Utilizing its proprietary drug discovery and development engine, Co. is developing selective small molecules designed to modulate the immune responses underlying these diseases. Co.'s main inflammation drug candidate, RPT193, and its main oncology drug candidate, FLX475, each target C-C motif chemokine receptor 4, a drug target that potentially has applicability in inflammatory diseases and oncology.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,568,900 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,503,500 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
4,898 |
9,898 |
52,860 |
| Total Sell Value |
$0 |
$95,236 |
$181,961 |
$1,173,761 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
3 |
5 |
17 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Column Group Llc |
10% Owner |
– – • |
2021-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,166,666) |
1,402,008 |
|
- |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-09-10 |
4 |
AS |
$35.78 |
$94,745 |
D/D |
(2,648) |
19,812 |
|
-40% |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-09-10 |
4 |
OE |
$6.18 |
$16,365 |
D/D |
2,648 |
22,460 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-09-08 |
4 |
AS |
$36.04 |
$108,120 |
D/D |
(3,000) |
65,106 |
|
-35% |
|
| Column Group Llc |
10% Owner |
– – • |
2021-09-02 |
4 |
S |
$35.43 |
$1,314,552 |
I/I |
(37,101) |
0 |
|
18% |
|
| Column Group Llc |
10% Owner |
– – • |
2021-09-01 |
4 |
S |
$35.02 |
$1,118,592 |
I/I |
(31,749) |
18,556 |
|
13% |
|
| Robbins Wendye |
|
– • – |
2021-08-24 |
4 |
B |
$30.81 |
$16,270 |
I/I |
525 |
2,000 |
0.01 |
24% |
|
| Column Group Llc |
10% Owner |
– – • |
2021-08-24 |
4 |
S |
$30.79 |
$718,413 |
I/I |
(22,867) |
0 |
|
-24% |
|
| Robbins Wendye |
|
– • – |
2021-08-23 |
4 |
B |
$31.00 |
$46,295 |
I/I |
1,475 |
1,475 |
0.01 |
24% |
|
| Column Group Llc |
10% Owner |
– – • |
2021-08-23 |
4 |
S |
$30.92 |
$2,141,570 |
I/I |
(68,340) |
11,418 |
|
-24% |
|
| Column Group Llc |
10% Owner |
– – • |
2021-08-20 |
4 |
S |
$30.07 |
$136,533 |
I/I |
(4,539) |
34,076 |
|
-23% |
|
| Robbins Wendye |
|
– • – |
2021-08-20 |
4 |
B |
$29.47 |
$17,717 |
D/D |
600 |
8,400 |
0.01 |
23% |
|
| Column Group Llc |
General Partner |
– – • |
2021-08-18 |
4 |
A |
$0.00 |
$0 |
I/I |
373,090 |
35,746 |
|
- |
|
| Column Group Llc |
General Partner |
– – • |
2021-08-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(208,403) |
0 |
|
- |
|
| Column Group Llc |
General Partner |
– – • |
2021-08-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,317,005) |
2,568,674 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-08-16 |
4 |
AS |
$32.07 |
$32,070 |
D/D |
(1,000) |
68,106 |
|
19% |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-08-11 |
4 |
AS |
$31.19 |
$82,560 |
D/D |
(2,647) |
19,812 |
|
-0% |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-08-11 |
4 |
OE |
$6.18 |
$16,358 |
D/D |
2,647 |
22,459 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-08-06 |
4 |
OE |
$12.00 |
$44,280 |
D/D |
3,690 |
69,106 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-08-04 |
4 |
OE |
$6.18 |
$4,331 |
D/D |
694 |
65,416 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-08-02 |
4 |
AS |
$30.52 |
$30,520 |
D/D |
(1,000) |
64,722 |
|
-0% |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-07-23 |
4 |
OE |
$6.18 |
$51,283 |
D/D |
8,193 |
65,722 |
|
- |
|
| Ho William |
Chief Medical Officer |
• – – |
2021-07-15 |
4 |
AS |
$30.23 |
$30,230 |
D/D |
(1,000) |
57,529 |
|
17% |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-07-12 |
4 |
AS |
$33.53 |
$88,787 |
D/D |
(2,648) |
19,812 |
|
10% |
|
| Brockstedt Dirk G. |
Chief Scientific Officer |
• – – |
2021-07-12 |
4 |
OE |
$6.18 |
$16,365 |
D/D |
2,648 |
22,460 |
|
- |
|
204 Records found
|
|
Page 4 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.05 (0.67%) 
